Autophagy preserves hematopoietic stem cells by restraining MTORC1-mediated cellular anabolism

被引:6
作者
Borsa, Mariana [1 ,5 ]
Obba, Sandrine [1 ]
Richter, Felix C. [1 ]
Zhang, Hanlin [1 ]
Riffelmacher, Thomas [1 ]
Carrelha, Joana [2 ]
Alsaleh, Ghada [1 ]
Jacobsen, Sten Eirik W. [2 ,3 ]
Simon, Anna Katharina [1 ,4 ,6 ]
机构
[1] Univ Oxford, Kennedy Inst Rheumatol NDORMS, Oxford, England
[2] Univ Oxford, Radcliffe Dept Med, MRC Mol Haematol Unit, MRC WIMM, Oxford, England
[3] Karolinska Inst, Dept Med H7, Stockholm, Sweden
[4] Max Delbruck Ctr Mol Med, Berlin, Germany
[5] Kennedy Inst Rheumatol, NDORMS, Roosevelt Dr, Oxford OX3 7FY, England
[6] Kennedy Inst Rheumatol NDORMS, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany
基金
英国惠康基金;
关键词
Autophagy; amino acids; hematopoietic stem cells; MTOR; rapamycin; translation; METABOLISM; SURVIVAL; GLYCOLYSIS; INTEGRITY; GROWTH; MTORC1; ACIDS;
D O I
10.1080/15548627.2023.2247310
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Adult stem cells are long-lived and quiescent with unique metabolic requirements. Macroautophagy/autophagy is a fundamental survival mechanism that allows cells to adapt to metabolic changes by degrading and recycling intracellular components. Here we address why autophagy depletion leads to a drastic loss of the stem cell compartment. Using inducible deletion of autophagy specifically in adult hematopoietic stem cells (HSCs) and in mice chimeric for autophagy-deficient and normal HSCs, we demonstrate that the stem cell loss is cell-intrinsic. Mechanistically, autophagy-deficient HSCs showed higher expression of several amino acid transporters (AAT) when compared to autophagy-competent cells, resulting in increased amino acid (AA) uptake. This was followed by sustained MTOR (mechanistic target of rapamycin) activation, with enlarged cell size, glucose uptake and translation, which is detrimental to the quiescent HSCs. MTOR inhibition by rapamycin treatment in vivo was able to rescue autophagy-deficient HSC loss and bone marrow failure and resulted in better reconstitution after transplantation. Our results suggest that targeting MTOR may improve aged stem cell function, promote reprogramming and stem cell transplantation.List of abbreviations: 5FU: fluoracil; AA: amino acids; AKT/PKB: thymoma viral proto-oncogene 1; ATF4: activating transcription factor 4; BafA: bafilomycin A1; BM: bone marrow; EIF2: eukaryotic initiation factor 2; EIF4EBP1/4EBP1: eukaryotic translation initiation factor 4E binding protein 1; KIT/CD117/c-Kit: KIT proto-oncogene receptor tyrosine kinase; HSCs: hematopoietic stem cells; HSPCs: hematopoietic stem and progenitor cells; Kyn: kynurenine; LSK: lineage- (Lin-), LY6A/Sca-1+, KIT/c-Kit/CD117+; LY6A/Sca-1: lymphocyte antigen 6 family member A; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; MTORC2: MTOR complex 2; OPP: O-propargyl-puromycin; PI3K: phosphoinositide 3-kinase; poly(I:C): polyinosinic:polycytidylic acid; RPS6/S6: ribosomal protein S6; tam: tamoxifen; TCA: tricarboxylic acid; TFEB: transcription factor EB; PTPRC/CD45: Protein Tyrosine Phosphatase Receptor Type C, CD45 antigen.
引用
收藏
页码:45 / 57
页数:13
相关论文
共 50 条
  • [41] Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function
    Hinden, Liad
    Ahmad, Majdoleen
    Hamad, Sharleen
    Nemirovski, Alina
    Szanda, Gergo
    Glasmacher, Sandra
    Kogot-Levin, Aviram
    Abramovitch, Rinat
    Thorens, Bernard
    Gertsch, Jurg
    Leibowitz, Gil
    Tam, Joseph
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [42] A mTORC1-mediated cyst(e)ine sensing mechanism governing GPX4 synthesis and ferroptosis
    Yan, Yuelong
    Lei, Guang
    Gan, Boyi
    MOLECULAR & CELLULAR ONCOLOGY, 2021, 8 (03)
  • [43] The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells
    Kahn, Jenna
    Hayman, Thomas J.
    Jamal, Muhammad
    Rath, Barbara H.
    Kramp, Tamalee
    Camphausen, Kevin
    Tofilon, Philip J.
    NEURO-ONCOLOGY, 2014, 16 (01) : 29 - 37
  • [44] Reconstitution of leucine-mediated autophagy via the mTORC1-Barkor pathway in vitro
    Yan, Xianghua
    Sun, Qiming
    Ji, Jian
    Zhu, Yaqin
    Liu, Zhengfei
    Zhong, Qing
    AUTOPHAGY, 2012, 8 (02) : 213 - 221
  • [45] Induction of autophagy by dual mTORC1-mTORC2 inhibition in BCR-ABL-expressing leukemic cells
    Vakana, Eliza
    Sassano, Antonella
    Platanias, Leonidas C.
    AUTOPHAGY, 2010, 6 (07) : 966 - 967
  • [46] Smooth muscle protein-22-mediated deletion of Tsc1 results in cardiac hypertrophy that is mTORC1-mediated and reversed by rapamycin
    Malhowski, Amy J.
    Hira, Haider
    Bashiruddin, Sarah
    Warburton, Rod
    Goto, June
    Robert, Blanton
    Kwiatkowski, David J.
    Finlay, Geraldine A.
    HUMAN MOLECULAR GENETICS, 2011, 20 (07) : 1290 - 1305
  • [47] mTORC1 signaling governs hematopoietic stem cell quiescence
    Gan, Boyi
    DePinho, Ronald A.
    CELL CYCLE, 2009, 8 (07) : 1003 - 1006
  • [48] CELLULAR RECYCLING GONE WRONG: THE ROLE OF DYSREGULATED AUTOPHAGY AND HYPERACTIVE MTORC1 IN THE PATHOGENESIS OF SARCOIDOSIS
    Adouli, Jennifer N.
    Fried, Aaron J.
    Swier, Rachel M.
    Ghio, Andrew J.
    Petrache, Irina
    Tilley, Stephen L.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2023, 40 (02)
  • [49] Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis
    Pan, Hongjie
    Zhong, Xiao-ping
    Lee, Sunhee
    BMC BIOCHEMISTRY, 2016, 17
  • [50] The autophagy Protein Atg5 Plays a Crucial Role in the Maintenance and Reconstitution Ability of Hematopoietic Stem Cells
    Jung, Hi Eun
    Shim, Ye Ri
    Oh, Ji Eun
    Oh, Dong Sun
    Lee, Heung Kyu
    IMMUNE NETWORK, 2019, 19 (02)